Found 3 clinical trials
RSV Vaccine
ARE YOU AGED 60 OR OLDER?Take part in a study assessing an investigational study vaccine to prevent respiratory syncytial virus (RSV) disease. Older adults are at an increased risk of developing serious complications, including inflammation of the lungs or pneumonia, from respiratory syncytial virus, or RSV. Insurance is not needed …
- 7 views
- 02 Nov, 2021
- 1 location
Respiratory Syncytial Virus (RSV) Vaccine
The study will enroll up to 23,000 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and …
- 0 views
- 02 Feb, 2022
- 1 location
Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age
The purpose of this study is to evaluate the safety and immunogenicity of a single dose of the recombinant live-attenuated respiratory syncytial virus (RSV) vaccines, RSV ΔNS2/Δ1313/I1314L, RSV
- 82 views
- 05 Mar, 2022
- 16 locations